# Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

> **NCT01273207** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 7 (actual)

## Conditions studied

- Bronchiolitis Obliterans
- Constructive Bronchiolitis
- Graft Versus Host Disease
- Bronchiolitis, Exudative
- Bronchiolitis, Proliferative
- Graft-Versus-Host Disease

## Interventions

- **DRUG:** Cyclosporine Inhalation Solution (CIS)

## Key facts

- **NCT ID:** NCT01273207
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-02
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-23
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2020-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273207, "Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01273207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*